# Stage 11: Commercial & Product Strategy — Findings

Schema: `_core/FINDING-SCHEMA.md`. Draft and confirmed findings are kept in separate sections below — never merge them.

## Draft Findings

(hypotheses / observations not yet confirmed — MUST NOT be cited by other stages)

_None._

---

## Confirmed Findings

(meet the evidence standard in `_core/EVIDENCE-STANDARD.md` — safe to cite from later stages)

### F-11-01: The stated SaaS ambition (FEAT-021) remains an unscoped stub, while its risk precondition is explicitly armed

- **Current implementation**: `Clients/Sandy/_PRODUCT/EP-004_phase2-agentic/FEAT-021_saas-multi-tenant_FUTURE.md` remains a placeholder — "Acceptance criteria: TBD — to be scoped after Phase 1 closure", Status `FUTURE`, "Sprint(s): Not yet started" — unchanged in substance since Stage 02's read (2026-07-12). Re-verified by live read 2026-07-18; full excerpt in `evidence/11-business-context-excerpts.md` §1. Meanwhile RR-1 trigger (c) (`10-evaluation-assurance/outputs/residual-risk-register.md` §1) explicitly arms multi-tenant commercialisation as a re-opened human risk decision.
- **Intended design**: `Clients/Sandy/CLAUDE.md` records "Phase 2 (future): Agentic SaaS payroll platform. AI-powered. Broader market." as documented business intent (excerpt §3). No scoping, demand evidence, or risk decision exists behind it.
- **Identified gap**: the business's documented commercial ambition and the programme's risk framework both point at the same unmade decision bundle — product/market, RR-1 re-open, and scope (multi-operator, tenant management, billing) — with no scoped path between the current single-bureau posture and the ambition. Any Stage 12/13 output that assumes the SaaS trajectory without the bundle being decided would be building on an unscoped stub. Classified and forwarded in `outputs/product-scope-boundaries.md` §2.2; not proposed (and RR-1(c) not fired) by this stage.
- **Evidence**: `evidence/11-business-context-excerpts.md` §§1, 3 (live reads 2026-07-18; files sit outside the git repo, excerpts duplicated per the evidence standard); `residual-risk-register.md` §1 RR-1 trigger (c). Repo tree clean at `4abafdc` for all repo-internal citations.
- **Severity**: Medium (per `SEVERITY-MODEL.md` — no current harm; material planning risk if Stage 12/13 assume the ambition without the decision bundle)
- **Status**: confirmed
- **Date**: 2026-07-18
- **Raised by**: Stage 11 (scope-boundary analysis, Q4)

### F-11-02: No registered commercial-demand evidence exists for any capability

- **Current implementation**: a sweep of the programme's registered sources (`_inputs/source-register.md` S-01–S-09) and all stage `decisions.md` logs (2026-07-18) finds **zero** evidence-type-5 human statements and zero registered external sources recording client demand, a client request, willingness to pay, or competitive pricing for any of the 15 capabilities or for SaaS commercialisation. The only commercial records are type-4 documented *intent* (`Clients/Sandy/CLAUDE.md`, FEAT-020/021 stubs). Sweep recorded in `evidence/11-business-context-excerpts.md` §4.
- **Intended design**: the programme's own evidence standard (type 5) and this stage's CONTEXT anticipate business facts arriving as registered sources or logged human statements — the mechanism exists; no such facts have been supplied to date.
- **Identified gap**: every "differentiation" classification in `outputs/commercial-value-map.md` and every claim in `outputs/positioning-and-claims.md` is grounded in operational-outcome evidence and claimability — none is demand-validated. Downstream stages must read "DIF" as "credibly claimable," not "market-verified." Recorded as evidence gaps EG-004 (next-onboarding timing) and EG-005 (demand/willingness-to-pay) in `decision-queue.md` rather than invented.
- **Evidence**: `evidence/11-business-context-excerpts.md` §4 (absence sweep, dated); `_inputs/source-register.md` S-01–S-09 (no type-5/commercial entries); `_core/HUMAN-DECISIONS.md` (all entries are review-scope/architecture decisions, none commercial-demand statements).
- **Severity**: Low (per `SEVERITY-MODEL.md` — an evidence boundary correctly handled by recording gaps; would escalate only if later stages treated claimability as demand proof)
- **Status**: confirmed
- **Date**: 2026-07-18
- **Raised by**: Stage 11 (business-fact discipline, CONTEXT "Finding discipline")

---

## Parked / Rejected

_None._

## Next action

**Stage 11 executor pass complete — awaiting independent critic per `CRITIC.md`.**
